Your browser doesn't support javascript.
loading
The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants.
Stefanucci, Luca; Collins, Janine; Sims, Matthew C; Barrio-Hernandez, Inigo; Sun, Luanluan; Burren, Oliver S; Perfetto, Livia; Bender, Isobel; Callahan, Tiffany J; Fleming, Kathryn; Guerrero, Jose A; Hermjakob, Henning; Martin, Maria J; Stephenson, James; Paneerselvam, Kalpana; Petrovski, Slavé; Porras, Pablo; Robinson, Peter N; Wang, Quanli; Watkins, Xavier; Frontini, Mattia; Laskowski, Roman A; Beltrao, Pedro; Di Angelantonio, Emanuele; Gomez, Keith; Laffan, Mike; Ouwehand, Willem H; Mumford, Andrew D; Freson, Kathleen; Carss, Keren; Downes, Kate; Gleadall, Nick; Megy, Karyn; Bruford, Elspeth; Vuckovic, Dragana.
Affiliation
  • Stefanucci L; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Collins J; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Sims MC; British Heart Foundation, BHF Centre of Research Excellence, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Barrio-Hernandez I; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Sun L; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Burren OS; Department of Haematology, Barts Health NHS Trust, London, United Kingdom.
  • Perfetto L; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Bender I; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Callahan TJ; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.
  • Fleming K; Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
  • Guerrero JA; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
  • Hermjakob H; Department of Public Health and Primary Care, BHF Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Martin MJ; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Stephenson J; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
  • Paneerselvam K; Department of Biology and Biotechnology "C.Darwin," Sapienza University of Rome, Rome, Italy.
  • Petrovski S; Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
  • Porras P; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY.
  • Robinson PN; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
  • Wang Q; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Watkins X; Department of Haematology, Barts Health NHS Trust, London, United Kingdom.
  • Frontini M; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
  • Laskowski RA; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
  • Beltrao P; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
  • Di Angelantonio E; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
  • Gomez K; Centre for Genomics Research, Discovery Sciences, AstraZeneca, Cambridge, United Kingdom.
  • Laffan M; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Australia.
  • Ouwehand WH; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
  • Mumford AD; Genomic Medicine, The Jackson Laboratory, Farmington, CT.
  • Freson K; Institute for Systems Genomics, University of Connecticut, Farmington, CT.
  • Carss K; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
  • Downes K; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, United Kingdom.
  • Gleadall N; Department of Haematology, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Megy K; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Bruford E; British Heart Foundation, BHF Centre of Research Excellence, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Vuckovic D; Department of Clinical and Biomedical Sciences, Faculty of Health and Life Sciences RILD Building, University of Exeter Medical School, Exeter, United Kingdom.
Blood ; 142(24): 2055-2068, 2023 12 14.
Article in En | MEDLINE | ID: mdl-37647632
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Genome-Wide Association Study Type of study: Prognostic_studies Limits: Humans Language: En Journal: Blood Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Genome-Wide Association Study Type of study: Prognostic_studies Limits: Humans Language: En Journal: Blood Year: 2023 Document type: Article Affiliation country: Reino Unido Country of publication: Estados Unidos